79 related articles for article (PubMed ID: 2935180)
1. Reduction in murine Langerhans cell ATPase staining following topical but not systemic treatment with steroid and non-steroid immunosuppressants.
Halliday GM; Knight BA; Muller HK
Br J Dermatol; 1986 Jan; 114(1):83-9. PubMed ID: 2935180
[TBL] [Abstract][Full Text] [Related]
2. In vitro immunosuppressive effects of methotrexate and azathioprine on Langerhans cells.
Liu HN; Wong CK
Arch Dermatol Res; 1997 Jan; 289(2):94-7. PubMed ID: 9049043
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
4. Effects of therapy with azathioprine and prednisolone and ultraviolet irradiation on mouse skin immune function and immune cell markers.
Kelly GE; Scheibner A; Sheil AG
Immunol Cell Biol; 1987 Apr; 65 ( Pt 2)():153-61. PubMed ID: 2956183
[TBL] [Abstract][Full Text] [Related]
5. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and morphometric analysis of Langerhans cells in non-exposed skin in renal transplant patients.
Servitje O; Serón D; Ferrer I; Carrera M; Pagerols X; Peyri J
J Cutan Pathol; 1991 Apr; 18(2):106-11. PubMed ID: 1830323
[TBL] [Abstract][Full Text] [Related]
7. Pimecrolimus does not affect Langerhans cells in murine epidermis.
Meingassner JG; Kowalsky E; Schwendinger H; Elbe-Bürger A; Stütz A
Br J Dermatol; 2003 Oct; 149(4):853-7. PubMed ID: 14616380
[TBL] [Abstract][Full Text] [Related]
8. Effect of systemic and topical application of testosterone propionate on the density of epidermal Langerhans cells in the mouse.
Koyama Y; Nagao S; Ohashi K; Takahashi H; Marunouchi T
J Invest Dermatol; 1989 Jan; 92(1):86-90. PubMed ID: 2642515
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells.
Suzuki H; Wang B; Shivji GM; Toto P; Amerio P; Tomai MA; Miller RL; Sauder DN
J Invest Dermatol; 2000 Jan; 114(1):135-41. PubMed ID: 10620129
[TBL] [Abstract][Full Text] [Related]
10. Effect of glucocorticosteroids on epidermal Langerhans cells.
Belsito DV; Flotte TJ; Lim HW; Baer RL; Thorbecke GJ; Gigli I
J Exp Med; 1982 Jan; 155(1):291-302. PubMed ID: 6459400
[TBL] [Abstract][Full Text] [Related]
11. Scheduled and unscheduled DNA synthesis in epidermal cells of hairless mice treated with immunosuppressive drugs and UVB-UVA irradiation.
Kelly GE; Meikle W; Sheil AG
Br J Dermatol; 1987 Oct; 117(4):429-40. PubMed ID: 3676092
[TBL] [Abstract][Full Text] [Related]
12. A study of systemic and topical effects of topical steroid application through the comparison of two application schedules.
Fukaya Y; Masutani M; Koyama Y; Takahashi H; Ueda H
J Dermatol; 1990 Jan; 17(1):28-33. PubMed ID: 2329214
[TBL] [Abstract][Full Text] [Related]
13. Distribution of ATPase-positive Langerhans cells in normal adult human skin.
Chen H; Yuan J; Wang Y; Silvers WK
Br J Dermatol; 1985 Dec; 113(6):707-11. PubMed ID: 2420351
[TBL] [Abstract][Full Text] [Related]
14. ATPase and morphologic changes in Langerhans cells induced by epicutaneous application of a sensitizing dose of DNFB.
Hanau D; Fabre M; Schmitt DA; Lepoittevin JP; Stampf JL; Grosshans E; Benezra C; Cazenave JP
J Invest Dermatol; 1989 May; 92(5):689-94. PubMed ID: 2523942
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical tacrolimus 0.03% on long-term suberythemal ultraviolet B-irradiated epidermal Langerhans cells in mice.
Yin ZQ; Lu Y; Zhou BR; Guo Z; Luo D
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):521-3. PubMed ID: 22471949
[No Abstract] [Full Text] [Related]
16. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells.
Seiffert K; Hosoi J; Torii H; Ozawa H; Ding W; Campton K; Wagner JA; Granstein RD
J Immunol; 2002 Jun; 168(12):6128-35. PubMed ID: 12055224
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells.
Hoetzenecker W; Meingassner JG; Ecker R; Stingl G; Stuetz A; Elbe-Bürger A
J Invest Dermatol; 2004 Mar; 122(3):673-84. PubMed ID: 15086553
[TBL] [Abstract][Full Text] [Related]
18. [The effect of Tomesa therapy on epidermal Langerhans cells in experimental animals].
Gruner S; Zwirner A; Diezel W; Boonen H; Sönnichsen N
Dermatol Monatsschr; 1990; 176(7):399-402. PubMed ID: 2147911
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of systemic immune suppression by UV irradiation in vivo. II. The UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies.
Noonan FP; Bucana C; Sauder DN; De Fabo EC
J Immunol; 1984 May; 132(5):2408-16. PubMed ID: 6232317
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A does not modify Langerhans' cell number and distribution in normal human skin.
Urabe A; Haftek M; Kanitakis J; Schmitt D; Thivolet J
Acta Derm Venereol; 1989; 69(3):249-52. PubMed ID: 2566233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
